These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21155856)

  • 1. Granulocyte and monocyte adsorptive apheresis in the management of ulcerative colitis.
    Yamamoto T
    Aliment Pharmacol Ther; 2011 Jan; 33(2):288; author reply 289. PubMed ID: 21155856
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppression of inflammatory cytokine secretion by granulocyte/monocyte adsorptive apheresis in active ulcerative colitis.
    Andoh A; Tsujikawa T; Inatomi O; Deguchi Y; Hata K; Kitoh K; Sasaki M; Mitsuyama K; Fujiyama Y
    Ther Apher Dial; 2005 Apr; 9(2):123-7. PubMed ID: 15828923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role of granulocyte/monocyte adsorptive apheresis for ulcerative colitis with concomitant CMV infection.
    Nakase H; Matsuura M; Chiba T
    Aliment Pharmacol Ther; 2011 Feb; 33(4):497-8; author reply 498. PubMed ID: 21235601
    [No Abstract]   [Full Text] [Related]  

  • 4. Reduction of interleukin-6, interleukin-8, and anti-phosphatidylserine-prothrombin complex antibody by granulocyte and monocyte adsorption apheresis in a patient with pyoderma gangrenosum and ulcerative colitis.
    Kawakami T; Yamazaki M; Soma Y
    Am J Gastroenterol; 2009 Sep; 104(9):2363-4. PubMed ID: 19727102
    [No Abstract]   [Full Text] [Related]  

  • 5. Granulocyte and monocyte adsorptive apheresis in the treatment of active distal ulcerative colitis: a prospective, pilot study.
    Yamamoto T; Umegae S; Kitagawa T; Yasuda Y; Yamada Y; Takahashi D; Mukumoto M; Nishimura N; Yasue K; Matsumoto K
    Aliment Pharmacol Ther; 2004 Oct; 20(7):783-92. PubMed ID: 15379839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatment.
    Sakuraba A; Motoya S; Watanabe K; Nishishita M; Kanke K; Matsui T; Suzuki Y; Oshima T; Kunisaki R; Matsumoto T; Hanai H; Fukunaga K; Yoshimura N; Chiba T; Funakoshi S; Aoyama N; Andoh A; Nakase H; Mizuta Y; Suzuki R; Akamatsu T; Iizuka M; Ashida T; Hibi T
    Am J Gastroenterol; 2009 Dec; 104(12):2990-5. PubMed ID: 19724269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Usefulness of New Single-Needle Intensive Granulocyte and Monocyte Adsorptive Apheresis in Active Ulcerative Colitis Patients Without Corticosteroids and Biologics.
    Shimazu K; Fukuchi T; Kim I; Noguchi Y; Iwata M; Koyama S; Ubukata S; Tanaka A
    Ther Apher Dial; 2016 Aug; 20(4):383-9. PubMed ID: 27523079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-Needle Intensive Granulocyte and Monocyte Adsorptive Apheresis Is Suitable for Elderly Patients With Active Ulcerative Colitis Taking no Corticosteroids or Biologics.
    Fukuchi T; Koga H; Kaichi S; Ishikawa A; Horita T; Araki R; Yokota A; Namba Y; Kyo M; Eguchi T; Shimazu K
    Ther Apher Dial; 2019 Jun; 23(3):224-232. PubMed ID: 31025824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte and monocyte adsorption apheresis therapy modulates monocyte-derived dendritic cell function in patients with ulcerative colitis.
    Iwakami Y; Sakuraba A; Sato T; Takada Y; Izumiya M; Ichikawa H; Hibi T
    Ther Apher Dial; 2009 Apr; 13(2):138-46. PubMed ID: 19379153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review: granulocyte/monocyte adsorptive apheresis for ulcerative colitis.
    Thanaraj S; Hamlin PJ; Ford AC
    Aliment Pharmacol Ther; 2010 Dec; 32(11-12):1297-306. PubMed ID: 21050231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyoderma Gangrenosum with Ulcerative Colitis Successfully Treated by the Combination of Granulocyte and Monocyte Adsorption Apheresis and Corticosteroids.
    Ohno M; Koyama S; Ohara M; Shimamoto K; Kobayashi Y; Nakamura F; Mitsuru K; Andoh A
    Intern Med; 2016; 55(1):25-30. PubMed ID: 26726081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting clinical and endoscopic efficacies of selective leucocytapheresis for ulcerative colitis.
    Yamamoto T; Saniabadi AR; Maruyama Y; Umegae S; Matsumoto K
    Dig Liver Dis; 2007 Jul; 39(7):626-33. PubMed ID: 17532273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of granulocyte and monocyte adsorption apheresis for ulcerative colitis: a meta-analysis.
    Yoshino T; Nakase H; Minami N; Yamada S; Matsuura M; Yazumi S; Chiba T
    Dig Liver Dis; 2014 Mar; 46(3):219-26. PubMed ID: 24268950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with the outcomes in ulcerative colitis patients undergoing granulocyte and monocyte adsorptive apheresis as remission induction therapy: A multicenter cohort study.
    Ishiguro Y; Ohmori T; Umemura K; Iizuka M
    Ther Apher Dial; 2021 Aug; 25(4):502-512. PubMed ID: 33029920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis.
    Sands BE; Sandborn WJ; Feagan B; Löfberg R; Hibi T; Wang T; Gustofson LM; Wong CJ; Vandervoort MK; Hanauer S;
    Gastroenterology; 2008 Aug; 135(2):400-9. PubMed ID: 18602921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of granulocyte/monocyte apheresis therapy for active ulcerative colitis.
    Kanke K; Nakano M; Hiraishi H; Terano A
    Dig Liver Dis; 2004 Dec; 36(12):811-7. PubMed ID: 15646427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal features and granulocyte-monocyte-apheresis in steroid-dependent/refractory ulcerative colitis.
    D'Ovidio V; Aratari A; Viscido A; Marcheggiano A; Papi C; Capurso L; Caprilli R
    Dig Liver Dis; 2006 Jun; 38(6):389-94. PubMed ID: 16569521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adsorptive granulocyte and monocyte apheresis versus prednisolone in patients with corticosteroid-dependent moderately severe ulcerative colitis.
    Hanai H; Watanabe F; Yamada M; Sato Y; Takeuchi K; Iida T; Tozawa K; Tanaka T; Maruyama Y; Matsushita I; Iwaoka Y; Kikuch K; Saniabadi AR
    Digestion; 2004; 70(1):36-44. PubMed ID: 15297776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid induction of mucosal healing by intensive granulocyte and monocyte adsorptive aphaeresis in active ulcerative colitis patients without concomitant corticosteroid therapy.
    Fukuchi T; Nakase H; Ito D; Yamashita H; Matsuura M; Nagatani Y; Koga H; Senda K; Eguchi T; Ubukata S; Kawaguchi S; Ueda A; Tanaka T; Ohashi R; Otzuka M; Ashida K
    Aliment Pharmacol Ther; 2011 Sep; 34(5):583-5. PubMed ID: 21806645
    [No Abstract]   [Full Text] [Related]  

  • 20. The efficacy and safety of selective granulocyte and monocyte apheresis for inflammatory bowel disease: A meta-analysis.
    Liu Z; Jiang X; Sun C
    Eur J Intern Med; 2016 Dec; 36():e26-e27. PubMed ID: 27614377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.